Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 10% Owner | 4 | $0 | $0 | 2026-07-03 |
| Ma Stephen Hoi | Chief Financial Officer | 7 | $116.4K | $0 | 2026-04-17 |
| Ji Henry | Executive Chairperson | 11 | $549.6K | $97.5K | 2026-04-17 |
| Scilex Holding Co | 10% Owner | 3 | $0 | $12.81M | 2025-12-30 |
| Chun Jay | Director | 7 | $56.5K | $0 | 2025-10-08 |
| Followwill Dorman | Director | 7 | $990 | $0 | 2025-10-08 |
| Wu Yue Alexander | Director | 6 | $19.0K | $0 | 2025-10-08 |
| SHAH JAISIM | See Remarks | 11 | $197.3K | $0 | 2024-12-18 |
| Lemus David | Director | 3 | $1.8K | $0 | 2024-10-17 |
| Navani Annu | Director | 1 | $0 | $0 | 2024-08-16 |
| Sorrento Therapeutics, Inc. | 10% Owner | 9 | $430.9K | $0 | 2023-09-21 |
| Lee Tien-Li | Director | 1 | $0 | $0 | 2023-01-17 |
| Hamill Laura | Director | 1 | $0 | $0 | 2023-01-17 |
| Thompson Tommy G | Director | 1 | $0 | $0 | 2023-01-17 |
| CZEREPAK ELIZABETH | See Remarks | 1 | $0 | $0 | 2023-01-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| SCLX Stock Acquisition JV LLC | 10% Owner | J Other | 2026-07-03 | 2026-07-07 | 500,000 | — | $0 | 958,263 | SEC↗ |
| Ji Henry | Exec Chair, CEO and Presiden | S Sale deriv | 2026-04-17 | 2026-04-20 | 650,000 | $0.15 | $97.5K | 2,600,000 | SEC↗ |
| Ma Stephen Hoi | CFO, COO and Secretary | P Buy deriv | 2026-04-17 | 2026-04-20 | 650,000 | $0.15 | $97.5K | 650,000 | SEC↗ |
| Ji Henry | Exec Chair, CEO and Presiden | P Buy deriv | 2026-04-16 | 2026-04-20 | 3,250,000 | $0.15 | $487.5K | 3,250,000 | SEC↗ |
| Scilex Holding Co | 10% Owner | S Sale | 2025-12-30 | 2025-12-30 | 9,657,300 | $0.54 | $5.21M | 244,445,260 | SEC↗ |
| Scilex Holding Co | 10% Owner | S Sale | 2025-12-29 | 2025-12-30 | 7,310,984 | $0.66 | $4.83M | 254,102,560 | SEC↗ |
| Scilex Holding Co | 10% Owner | S Sale | 2025-12-26 | 2025-12-30 | 3,689,016 | $0.75 | $2.77M | 261,413,544 | SEC↗ |
| Followwill Dorman | Director | A Award deriv | 2025-10-08 | 2025-10-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ji Henry | CEO and President | A Award deriv | 2025-10-08 | 2025-10-09 | 120,000 | — | $0 | 120,000 | SEC↗ |
| Chun Jay | Director | A Award deriv | 2025-10-08 | 2025-10-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| Ma Stephen Hoi | CFO and COO | A Award deriv | 2025-10-08 | 2025-10-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2025-10-08 | 2025-10-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCLX Stock Acquisition JV LLC | 10% Owner | J Other | 2025-01-21 | 2025-01-23 | 3,250,000 | — | $0 | 51,039,214 | SEC↗ |
| SCLX Stock Acquisition JV LLC | 10% Owner | J Other | 2025-01-16 | 2025-01-17 | 779,371 | — | $0 | 54,289,214 | SEC↗ |
| SCLX Stock Acquisition JV LLC | 10% Owner | J Other | 2025-01-02 | 2025-01-06 | 5,000,000 | — | $0 | 55,068,585 | SEC↗ |
| SHAH JAISIM | See Remarks | P Buy | 2024-12-18 | 2024-12-18 | 30,000 | $0.46 | $13.8K | 139,333 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2024-12-16 | 2024-12-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Followwill Dorman | Director | A Award deriv | 2024-12-16 | 2024-12-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Chun Jay | Director | A Award deriv | 2024-12-16 | 2024-12-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Ji Henry | Executive Chairperson | P Buy | 2024-10-31 | 2024-10-31 | 8,888 | $0.94 | $8.4K | 320,161 | SEC↗ |
| SHAH JAISIM | See Remarks | P Buy | 2024-10-29 | 2024-10-29 | 32,000 | $0.99 | $31.7K | 109,333 | SEC↗ |
| Chun Jay | Director | P Buy | 2024-10-18 | 2024-10-18 | 5,000 | $0.95 | $4.8K | 112,500 | SEC↗ |
| Followwill Dorman | Director | P Buy | 2024-10-18 | 2024-10-18 | 1,000 | $0.99 | $990 | 2,300 | SEC↗ |
| Ji Henry | Executive Chairperson | P Buy | 2024-10-17 | 2024-10-18 | 10,000 | $0.97 | $9.7K | 60,070 | SEC↗ |
| Lemus David | Director | P Buy | 2024-10-17 | 2024-10-18 | 2,000 | $0.90 | $1.8K | 2,000 | SEC↗ |
| Wu Yue Alexander | Director | P Buy | 2024-10-17 | 2024-10-18 | 20,000 | $0.95 | $19.0K | 25,000 | SEC↗ |
| Ma Stephen Hoi | Chief Financial Officer | P Buy | 2024-10-16 | 2024-10-17 | 6,700 | $0.97 | $6.5K | 22,840 | SEC↗ |
| SHAH JAISIM | See Remarks | P Buy | 2024-10-16 | 2024-10-17 | 30,000 | $0.99 | $29.7K | 77,333 | SEC↗ |
| Navani Annu | Director | A Award deriv | 2024-08-16 | 2024-08-19 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Followwill Dorman | Director | M Exercise deriv | 2024-06-26 | 2024-06-26 | 1,000 | — | $0 | 99,000 | SEC↗ |
| Followwill Dorman | Director | M Exercise | 2024-06-26 | 2024-06-26 | 1,000 | $1.37 | $1.4K | 1,300 | SEC↗ |
| SHAH JAISIM | See Remarks | M Exercise deriv | 2024-06-20 | 2024-06-20 | 14,000 | — | $0 | 7,880,598 | SEC↗ |
| Chun Jay | Director | M Exercise deriv | 2024-06-20 | 2024-06-20 | 5,000 | — | $0 | 245,000 | SEC↗ |
| Ma Stephen Hoi | Chief Financial Officer | M Exercise deriv | 2024-06-20 | 2024-06-20 | 2,000 | — | $0 | 148,000 | SEC↗ |
| Wu Yue Alexander | Director | M Exercise deriv | 2024-06-20 | 2024-06-20 | 5,000 | — | $0 | 245,000 | SEC↗ |
| SHAH JAISIM | See Remarks | M Exercise | 2024-06-20 | 2024-06-20 | 14,000 | $1.73 | $24.2K | 47,333 | SEC↗ |
| Chun Jay | Director | M Exercise | 2024-06-20 | 2024-06-20 | 5,000 | $1.41 | $7.0K | 107,500 | SEC↗ |
| Ma Stephen Hoi | Chief Financial Officer | M Exercise | 2024-06-20 | 2024-06-20 | 2,000 | $1.41 | $2.8K | 16,140 | SEC↗ |
| Wu Yue Alexander | Director | M Exercise | 2024-06-20 | 2024-06-20 | 5,000 | $1.41 | $7.0K | 5,000 | SEC↗ |
| Ji Henry | Executive Chairperson | M Exercise deriv | 2024-06-18 | 2024-06-18 | 6,000 | — | $0 | 194,000 | SEC↗ |
| Ji Henry | Executive Chairperson | M Exercise | 2024-06-18 | 2024-06-18 | 6,000 | $1.41 | $8.5K | 311,273 | SEC↗ |
| SHAH JAISIM | See Remarks | M Exercise deriv | 2024-06-14 | 2024-06-14 | 33,333 | — | $0 | 166,667 | SEC↗ |
| SHAH JAISIM | See Remarks | M Exercise | 2024-06-14 | 2024-06-14 | 33,333 | $1.41 | $47.0K | 33,333 | SEC↗ |
| Ma Stephen Hoi | Chief Financial Officer | P Buy | 2024-05-17 | 2024-05-17 | 14,140 | $0.88 | $12.4K | 14,140 | SEC↗ |
| SHAH JAISIM | See Remarks | P Buy | 2024-05-17 | 2024-05-17 | 56,939 | $0.92 | $52.4K | 155,882 | SEC↗ |
| Chun Jay | Director | P Buy | 2024-05-17 | 2024-05-17 | 57,500 | $0.90 | $51.8K | 102,500 | SEC↗ |
| Ji Henry | Executive Chairperson | P Buy | 2024-05-17 | 2024-05-17 | 50,000 | $0.88 | $44.0K | 50,070 | SEC↗ |
| SHAH JAISIM | See Remarks | P Buy | 2024-05-16 | 2024-05-17 | 83,061 | $0.84 | $69.8K | 98,943 | SEC↗ |
| Followwill Dorman | Director | A Award deriv | 2024-03-15 | 2024-06-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Lemus David | Director | A Award deriv | 2024-03-15 | 2024-06-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Ma Stephen Hoi | Chief Financial Officer | A Award deriv | 2023-10-04 | 2023-10-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Chun Jay | Director | A Award deriv | 2023-10-04 | 2023-10-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Wu Yue Alexander | Director | A Award deriv | 2023-10-04 | 2023-10-05 | 250,000 | — | $0 | 250,000 | SEC↗ |
| SHAH JAISIM | See Remarks | A Award deriv | 2023-10-04 | 2023-10-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Ji Henry | Executive Chairperson | A Award deriv | 2023-10-04 | 2023-10-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | S Sale deriv | 2023-09-21 | 2023-09-25 | 4,490,617 | — | $0 | 0 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | S Sale | 2023-09-21 | 2023-09-25 | 60,068,585 | — | $0 | 1,917,210 | SEC↗ |
| Ji Henry | Executive Chairperson | J Other | 2023-03-17 | 2023-03-20 | 2,730 | $8.60 | $23.5K | 2,730 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | J Other | 2023-01-19 | 2023-01-23 | 73,740,795 | — | $0 | 61,985,795 | SEC↗ |
| Ji Henry | Executive Chairperson | A Award deriv | 2023-01-17 | 2023-01-17 | 9,000,000 | — | $0 | 9,000,000 | SEC↗ |
| SHAH JAISIM | See Remarks | A Award deriv | 2023-01-17 | 2023-01-17 | 1,700,000 | — | $0 | 1,700,000 | SEC↗ |
| CZEREPAK ELIZABETH | See Remarks | A Award deriv | 2023-01-17 | 2023-01-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| Lemus David | Director | A Award deriv | 2023-01-17 | 2023-01-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Hamill Laura | Director | A Award deriv | 2023-01-17 | 2023-01-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Lee Tien-Li | Director | A Award deriv | 2023-01-17 | 2023-01-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Thompson Tommy G | Director | A Award deriv | 2023-01-17 | 2023-01-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Followwill Dorman | Director | A Award deriv | 2023-01-17 | 2023-01-17 | 250,000 | — | $0 | 250,000 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | P Buy deriv | 2022-12-02 | 2022-12-02 | 224,841 | $0.35 | $78.7K | 4,490,617 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | P Buy deriv | 2022-11-25 | 2022-11-25 | 46,172 | $0.44 | $20.3K | 4,265,776 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | P Buy deriv | 2022-11-23 | 2022-11-23 | 442,829 | $0.40 | $177.1K | 4,219,604 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | P Buy deriv | 2022-11-22 | 2022-11-22 | 672,775 | $0.23 | $154.7K | 3,776,775 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | J Other deriv | 2022-11-10 | 2022-11-15 | 307,296 | — | $0 | 3,104,000 | SEC↗ |
| Sorrento Therapeutics, Inc. | 10% Owner | J Other deriv | 2022-11-10 | 2022-11-15 | 2,796,704 | — | $0 | 2,796,704 | SEC↗ |